Solorank
Login

Cached score snapshot

US.A · Agilent Technologies

110分制 60.8/110；5D動能v2 4/50；排序分 64.8/160

Back to ranking Open volume snapshot
Ranking score 64.8/160
Main score 60.8/110
5D momentum v2 4/50
Rank #262
Setup grade F 34.1

Score breakdown

觀望

Medium twelvedata

Score and price trend

F 34.1 Money flow A · Low sample confidence

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

0 40 80 110 Score 07-22 09-14 10-22 11-09 11-25 $127.18$163.19$199.21 Price Projection date
Historical projection
Model Median P25/P75 歷史相似情境上漲比例 Down5 Actual / compare
Rolling calibration best · score 2.504 · anchors 120 +0.84% -1.94% / +3.29% 65% 0% Actual -2.36% · vs median -3.20% · inside 25-75 band
30D observation -0.81% -6.43% / +7.55% 45% 30% Actual outcome pending · 1 / 30 bars observed
Historical projection 10D n=160 +0.25% -1.48% / +2.38% 55% 2.5% Actual outcome pending · 1 / 10 bars observed

歷史情境統計基於已存檔相似 setup；圖中投影中位線為統計中位數的線性插值展示，並非價格路徑預測或買賣建議。

2026-07-22 → 2026-11-25 · 148 archived points · 2 Improving turn signal · 4 Deteriorating signal · 1 Exit review signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 64.8
Display grade 觀望
Model version cursor_18_27_news_v2_160
Main score 60.8/110 (觀望)
5D momentum v2 4/50 (弱)
Score with momentum v2 64.8/160 (低排序)
Risk level Medium

Audit trace

Full calculation detail

Calculation detail · 8 sections

Market inputs

Bar count 60
ma20 168.766
ma50 157.571
close 174
prevClose 171.6
avgVolume20 2543985
volumeRatio 0.93
changePercent 1.4

Metrics snapshot

close 174
volume 2355695
changePercent 1.4

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 60.8/110
Main rating 觀望
5D momentum v2 4/50
Score with momentum v2 64.8/160
Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 3.6/5 · 良好
Dimension score 3.6/5
Dimension grade 良好

Sub-items

pbPoints 0.2
pePoints 0.2
epsPoints 0
roePoints 0.75
debtPoints 0.5
marginPoints 0.6
turnoverUsdM 409.8909
volumePoints 0.5
revenuePoints 0
dividendPoints 0.3
marketCapPoints 0.5

資金流 — 14.8/20 · 良好
Dimension score 14.8/20
Dimension grade 良好

Sub-items

cmfPoints 3.2
mfiPoints 2.4
obvPoints 3.2
vwapPoints 4

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL
symbol US.A
message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.
optional true
holderCount n/a
holderPoints 2
top10ShareRatio n/a
concentrationPenalty 0
institutionPoints 2

市場環境 — 12.2/15 · 優秀
Dimension score 12.2/15
Dimension grade 優秀

Sub-items

vix

score 2.4

details

source twelvedata+fred
vixClose 15.27

trend

score 2.8

details

qqq

ma20 742.542
ma50 726.6542
name QQQ
close 728.84
points 1.4

spy

ma20 770.6465
ma50 768.568
name SPY
close 769.6
points 1.4
source twelvedata+fred
atrPct 2.6486
atrPoints 3
cciPoints 4
vixPoints 2.4
marketTrendPoints 2.8

催化劑 — 2/20 · 較差
Dimension score 2/20
Dimension grade 較差

Sub-items

catalyst

score 2

details

source finnhub_news_keyword_model
articleCount 8
catalystCount 0
catalystPoints 2

風險管理 — 6.8/10 · 一般
Dimension score 6.8/10
Dimension grade 一般

Sub-items

position

score 1.6

details

atrPct 2.6486
turnoverUsdM 409.8909
liquidityPoints 0.6
volatilityPoints 1
rrPoints 1.4

stopLevels

symbol US.A
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 164.7828

strength_details

ma_score 1.5
atr_score 2
rsi_score 2
macd_score 1.5
volume_score 1
market_adjustment 1
risk_reward_ratio 1
stop_loss_percent 5.3
take_profit_price 183.1942
target_multiplier 1.9
technical_strength 1.58
take_profit_percent 5.3
positionPoints 1.6
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 5.2972
diversificationPoints 2

技術信號 — 19.4/30 · 一般
Dimension score 19.4/30
Dimension grade 一般

Sub-items

bbPoints 3
adxPoints 3
sarPoints 1.8
vcpPoints 1.6
macdPoints 2.4

vcpPayload

vcp_pass false
vcp_score 1.6
vcp_reason 波幅收縮(20.6%→7.5%)；站上MA50；Ready=N；Confirm=N

vcp_metrics

up_days 5
vol_ref 2368056.6667
down_days 4
vcp_ready false
above_ma50 true
avg_vol_10 2116740
avg_vol_20 2551585
avg_vol_30 2368056.6667
range_pct_10 0.0751
range_pct_20 0.1537
range_pct_30 0.2057
up_expand_ok false
lookback_used 59
near_20d_high true
contraction_ok true
down_shrink_ok false
up_expand_days 0
breakout_20d_ok false
vol_ratio_10_30 0.8939
dist_to_20d_high 0.0172
down_shrink_days 1
breakout_level_20d 177.05
vcp_breakout_confirm false
contraction_ratio_10_30 0.3648
vcp_name_en Volatility Contraction Pattern
vcp_name_zh 波動收縮形態
vol_contraction true
kdjAdxPoints 0.8
rsiKdjPoints 3.2
volumeWeight 2
maCrossPoints 1.6
shortRsiPoints 0.8
shortMacdPoints 0.4
volConfirmPoints 0
volumePointsTechnical 0.8

情緒分析 — 2/10 · 較差
Dimension score 2/10
Dimension grade 較差

Sub-items

sentiment

score 2

details

source finnhub_news_keyword_model
articleCount 8
negativeHits 0
positiveHits 0
sentimentScoreRaw 0

sentimentData

raw {"id":142820200,"url":"https://finnhub.io/api/news?id=e5b5228a892afb854995ba185b865f6af7d31e47c95767cdc2d37e77e167926f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Here is how Agilent Technologies (A) and Concentra Group (CON) have performed compared to their sector so far this year.","category":"company","datetime":1791808802,"headline":"Is Agilent Technologies (A) Outperforming Other Medical Stocks This Year?"}, {"id":142731215,"url":"https://finnhub.io/api/news?id=b9ad7f7c83f68f77f768b32672fe150f58440903e569bbc9921aca0b44bb676c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Agilent Technologies has delivered a solid share price run over recent years, and the question now is whether the current valuation is properly backed by the cash the business can generate. With fresh investment in new labs and instruments on the table, investors are asking how those projects feed into the stock's intrinsic value based on its cash flows. Over the past 3 years the stock has returned 52.5%, which puts real weight on whether cash generation can support the price that move has...","category":"company","datetime":1791479981,"headline":"Is Agilent Technologies (A) Cheap Enough To Justify Its Cash Flow?"}, {"id":142633835,"url":"https://finnhub.io/api/news?id=2eb8408fc2372f0d7df88dbbc9133e3a1155d872cc69ffa7774a7678864fa389","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2276411485/image_2276411485.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"A","summary":"First Trust Water ETF keeps underperforming the broader market, implying that there's more to consider than just demand. I rate the FIW ETF as Sell. Click to read my analysis.","category":"company","datetime":1791185457,"headline":"FIW: Massive Water Infrastructure Needs Aren't Enough To Justify A Buy"}, {"id":142445426,"url":"https://finnhub.io/api/news?id=9c786dfccd5c711947457a233c7a6a55226c5e0c02b2d5e54c9a5e36229e194e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Agilent Technologies (A) drew fresh investor attention after announcing a fixed income exchange offer for its 4.900% senior unsecured notes due January 15, 2032, covering a principal amount of US$600 million. Recent action around Agilent Technologies reflects that investors are leaning into the story again, with a 7 day share price return of 10.43% and a 90 day share price return of 30.08% helping lift the stock to US$172.79. That momentum sits on top of a 1 year total shareholder return of...","category":"company","datetime":1790489579,"headline":"Agilent Technologies (A) Tests Valuation On Exchange Offer And Recurring Revenue Story"}, {"id":142424027,"url":"https://finnhub.io/api/news?id=21f3938831580f724b9108ab61b3b50cce4c3608a5dfc9c7465bba7828a0d0f6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1790346602,"headline":"Agilent (A) Up 9.6% Since Last Earnings Report: Can It Continue?"}, {"id":142359782,"url":"https://finnhub.io/api/news?id=2efb73205e56e8222fc2807fee31ad68e98497908bfe9dc63b4c19798931f4ce","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.","category":"company","datetime":1790166613,"headline":"If You Invested $1000 in Agilent Technologies a Decade Ago, This is How Much It'd Be Worth Now"}, {"id":142361017,"url":"https://finnhub.io/api/news?id=370b63c77df39cee79edef82022a7c1815f2f1568590cf120b0fa4321350be66","image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","source":"SeekingAlpha","related":"A","summary":"Agilent Technologies, Inc. (A) U.S.","category":"company","datetime":1790158171,"headline":"Agilent Technologies, Inc. (A) Presents at U.S. All Stars Conference Transcript"}, {"id":142337961,"url":"https://finnhub.io/api/news?id=2a763a94071e5b5b3e92356501cf788fc2932bb0f3fc59f8286178b69e923cfd","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Let’s dig into the relative performance of Agilent (NYSE:A) and its peers as we unravel the now-completed Q2 research tools & consumables earnings season.","category":"company","datetime":1790085466,"headline":"Research Tools & Consumables Stocks Q2 Highlights: Agilent (NYSE:A)"}
raw_source {"id":142880640,"url":"https://finnhub.io/api/news?id=f59fb84a1dddc2400f63f414be29dad3e7429ba4db920560f5af7615a7d1d9b4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"The transaction, which is expected to close in Agilent’s fiscal year 2027, follows its $950m acquisition of Biocare Medical in March 2026.","category":"company","datetime":1791976316,"headline":"Agilent acquires Proscia in deal worth up to $270m"}, {"id":142884529,"url":"https://finnhub.io/api/news?id=c5802bcda140f286c39d247fed77151eb14a83c236706ed9d72001d98e550db9","image":"https://cdn.benzinga.com/files/images/story/2026/10/14/Business-Mergers-And-Acquisitions-Concep.jpg?width=2048&height=1536","source":"Benzinga","related":"A","summary":"Agilent (A) to acquire Proscia for up to $270M to expand AI-powered digital pathology & diagnostic capabilities. Stock edges higher.","category":"company","datetime":1791969631,"headline":"Why Agilent Is Spending up to $270 Million on an AI Pathology Specialist"}, {"id":142872383,"url":"https://finnhub.io/api/news?id=f787c7b9b42d55a03cd4a0b6dcda8b2030c5da929b0fc2afc9f13417433f89b2","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Players: Metabolon, Bruker, Agilent, Thermo Fisher and Waters. Profiles cover products, services, market share, segments, trends, opportunities and regional presence.Dublin, Oct. 14, 2026 (GLOBE NEWSWIRE) -- \"Metabolomics Market Report 2026\" has been added to ResearchAndMarkets.com's offering. The global metabolomics market is experiencing rapid expansion, driven by advances in biomarker discovery, personalized medicine, cancer research and analytical technologies. The market grew from $4.17 bil","category":"company","datetime":1791965160,"headline":"Global Metabolomics Market Report 2026: Size, Trends, and Forecast to 2030 | Capitalize on 17.3% CAGR as Thermo Fisher, Bruker, Agilent, and Metabolon Accelerate AI Diagnostics"}, {"id":142885464,"url":"https://finnhub.io/api/news?id=ca55eb1d7732b96a5721dd224220baa4cbf255435598a2e7e851fcfae6a23d8d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"The digital pathology firm “fits in very well” with Agilent and moves the company into a sector targeted by Roche, analysts said.","category":"company","datetime":1791959378,"headline":"Agilent to buy Proscia for $240M"}, {"id":142849053,"url":"https://finnhub.io/api/news?id=6fc26925705f3d72cf48b269551fa1c08ea36bb23b3f1ba47d48926b51183b6e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"SANTA CLARA, Calif. & PHILADELPHIA, October 13, 2026--Agilent Technologies Inc. (NYSE: A) today announced it has entered into a definitive agreement to acquire Proscia®, a provider of digital pathology software for clinical and life-sciences customers, in an all-cash transaction valued at $240 million in cash at closing and up to an additional $30 million based on achieving future performance milestones.","category":"company","datetime":1791892800,"headline":"Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence"}, {"id":142884530,"url":"https://finnhub.io/api/news?id=c1b0d7a8d698fe1997b21a865b7d9783823b5719b16985faf0da984950fc4655","image":"","source":"Benzinga","related":"A","summary":"TD Cowen analyst Dan Brennan maintains Agilent Technologies (NYSE:A) with a Buy and raises the price target from $180 to $196.","category":"company","datetime":1791891562,"headline":"TD Cowen Maintains Buy on Agilent Technologies, Raises Price Target to $196"}, {"id":142884531,"url":"https://finnhub.io/api/news?id=9b35f2007459e45e29c82c9aa6d0e52a64c4e923f02492cd7953b9ea18d2b71a","image":"","source":"Benzinga","related":"A","summary":"Morgan Stanley analyst Kallum Titchmarsh maintains Agilent Technologies (NYSE:A) with a Overweight and raises the price target from $175 to $190.","category":"company","datetime":1791891494,"headline":"Morgan Stanley Maintains Overweight on Agilent Technologies, Raises Price Target to $190"}, {"id":142839262,"url":"https://finnhub.io/api/news?id=d2236c8c28c291f8d06435628151897272438e2c76e2f409c8bed47f16e3d589","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- \"Chromosomal Microarray Reflex Testing Global Market Report 2026\" has been added to ResearchAndMarkets.com's offering. The global chromosomal microarray reflex testing market is experiencing strong growth as healthcare providers increase their use of advanced genomic diagnostics for prenatal, postnatal, oncology, and rare disease applications. The market is projected to grow from $1.39 billion in 2025 to $1.51 billion in 2026, representing a compound ann","category":"company","datetime":1791878580,"headline":"Global Chromosomal Microarray Reflex Testing Market Report 2026-2030 | Capitalize on 9.1% CAGR as Thermo Fisher, LabCorp, Illumina, Agilent, and Natera Scale Precision Genomics"}, {"id":142820200,"url":"https://finnhub.io/api/news?id=e5b5228a892afb854995ba185b865f6af7d31e47c95767cdc2d37e77e167926f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Here is how Agilent Technologies (A) and Concentra Group (CON) have performed compared to their sector so far this year.","category":"company","datetime":1791808802,"headline":"Is Agilent Technologies (A) Outperforming Other Medical Stocks This Year?"}, {"id":142731215,"url":"https://finnhub.io/api/news?id=b9ad7f7c83f68f77f768b32672fe150f58440903e569bbc9921aca0b44bb676c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Agilent Technologies has delivered a solid share price run over recent years, and the question now is whether the current valuation is properly backed by the cash the business can generate. With fresh investment in new labs and instruments on the table, investors are asking how those projects feed into the stock's intrinsic value based on its cash flows. Over the past 3 years the stock has returned 52.5%, which puts real weight on whether cash generation can support the price that move has...","category":"company","datetime":1791479981,"headline":"Is Agilent Technologies (A) Cheap Enough To Justify Its Cash Flow?"}, {"id":142695688,"url":"https://finnhub.io/api/news?id=54b2461c864239e33dfabc7a5f3aa6a8062696dfa72aec15a19b4970dde3fecc","image":"","source":"Benzinga","related":"A","summary":"Barclays analyst Luke Sergott maintains Agilent Technologies (NYSE:A) with a Overweight and raises the price target from $175 to $195.","category":"company","datetime":1791365165,"headline":"Barclays Maintains Overweight on Agilent Technologies, Raises Price Target to $195"}, {"id":142647609,"url":"https://finnhub.io/api/news?id=c842fcc48355b415ae781153021086982bc5ef2315cf2c17223cf25039995173","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2163482326/image_2163482326.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"A","summary":"Technology was the only sector to gain in September as mega-cap strength masked broad market weakness. Read more here.","category":"company","datetime":1791250200,"headline":"Moat Stocks Retreat As Market Breadth Narrows"}, {"id":142633835,"url":"https://finnhub.io/api/news?id=2eb8408fc2372f0d7df88dbbc9133e3a1155d872cc69ffa7774a7678864fa389","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2276411485/image_2276411485.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"A","summary":"First Trust Water ETF keeps underperforming the broader market, implying that there's more to consider than just demand. I rate the FIW ETF as Sell. Click to read my analysis.","category":"company","datetime":1791185457,"headline":"FIW: Massive Water Infrastructure Needs Aren't Enough To Justify A Buy"}, {"id":142593872,"url":"https://finnhub.io/api/news?id=499bf9bb38b2e7b37ffd4baa210386aa2765fea7f5aabdb08f96d7dabdf7322d","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"A","summary":"Track weekly dividend updates for Dividend Champions, Contenders & Challengers—see dividend changes, upcoming ex-dividend and pay dates. Read it here.","category":"company","datetime":1790965134,"headline":"Dividend Champion, Contender, And Challenger Highlights: Week October 4"}, {"id":142559868,"url":"https://finnhub.io/api/news?id=8b175ceb5b7bff39983b76422ee597a0905fad70b8d2ff3eeb3a31a160e63ea4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1790865004,"headline":"Why Is Medtronic (MDT) Down 6.4% Since Last Earnings Report?"}, {"id":142588193,"url":"https://finnhub.io/api/news?id=309bd205640725159056e0eb9ab31f49a57990c5d5ed2d0ca8a7b06b3613fb67","image":"https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_3.jpg?width=2048&height=1536","source":"Benzinga","related":"A","summary":"Agilent Technologies (NYSE:A) has outperformed the market over the past 15 years by 1.05% on an annualized basis producing an average annual return of 14.43%. Currently, Agilent Technologies has a market capitalization","category":"company","datetime":1790858747,"headline":"$1000 Invested In Agilent Technologies 15 Years Ago Would Be Worth This Much Today"}, {"id":142557959,"url":"https://finnhub.io/api/news?id=8a17cf1a74d2ef0a8e32e203d206f2395bdb550fe0f0e12abcf88e004c2922dc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"SANTA CLARA, Calif., October 01, 2026--Agilent Technologies Inc. (NYSE: A) today announced the launch of the NovoStation Sample Preparation System, a new automated platform designed to help laboratories simplify and streamline flow cytometry sample preparation. When paired with a NovoCyte flow cytometer and NovoExpress software, NovoStation offers an integration-ready solution that enables a hands-free sample-to-answer workflow, helping scientists spend less time preparing samples and more time","category":"company","datetime":1790856000,"headline":"Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows"}, {"id":142496160,"url":"https://finnhub.io/api/news?id=ef18193aa55d6b8032d176e715ec487656be230854007991936e0d42bbb488e7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"SANTA CLARA, Calif., September 29, 2026--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent BioTek Gen5 AI cell identification module, a new image analysis software add-on that incorporates AI-based cell identification and segmentation into BioTek Gen5 imaging analysis.","category":"company","datetime":1790683200,"headline":"Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers"}, {"id":142463307,"url":"https://finnhub.io/api/news?id=2a2c59b622ef2cae5b0b5c0f8089761a5aa4c5cfac4ea08d75d8dc51e8bbe26b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 46.9% gain over the past six months, beating the S&P 500 by 25.5 percentage points.","category":"company","datetime":1790587116,"headline":"3 Healthcare Stocks That Fall Short"}, {"id":142445426,"url":"https://finnhub.io/api/news?id=9c786dfccd5c711947457a233c7a6a55226c5e0c02b2d5e54c9a5e36229e194e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Agilent Technologies (A) drew fresh investor attention after announcing a fixed income exchange offer for its 4.900% senior unsecured notes due January 15, 2032, covering a principal amount of US$600 million. Recent action around Agilent Technologies reflects that investors are leaning into the story again, with a 7 day share price return of 10.43% and a 90 day share price return of 30.08% helping lift the stock to US$172.79. That momentum sits on top of a 1 year total shareholder return of...","category":"company","datetime":1790489579,"headline":"Agilent Technologies (A) Tests Valuation On Exchange Offer And Recurring Revenue Story"}, {"id":142424027,"url":"https://finnhub.io/api/news?id=21f3938831580f724b9108ab61b3b50cce4c3608a5dfc9c7465bba7828a0d0f6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1790346602,"headline":"Agilent (A) Up 9.6% Since Last Earnings Report: Can It Continue?"}, {"id":142385317,"url":"https://finnhub.io/api/news?id=f6f2a26b9f5647288b5da04eda91284fe1679478b8b585e97013ed1ba637efe8","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"A","summary":"Stay updated with the movements of the S&P500 index one hour before the close of the markets on Thursday. Discover which stocks are leading as top gainers and losers in today's session.","category":"company","datetime":1790276701,"headline":"Discover which S&P500 stocks are making waves on Thursday."}, {"id":142384123,"url":"https://finnhub.io/api/news?id=dc1a57203f768e8c465d0c09732c290a21cef549361c1549da309d17b77fc56a","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"A","summary":"Curious about the top performers within the S&P500 index in the middle of the day on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.","category":"company","datetime":1790267701,"headline":"Explore the top gainers and losers within the S&P500 index in today's session."}, {"id":142359782,"url":"https://finnhub.io/api/news?id=2efb73205e56e8222fc2807fee31ad68e98497908bfe9dc63b4c19798931f4ce","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.","category":"company","datetime":1790166613,"headline":"If You Invested $1000 in Agilent Technologies a Decade Ago, This is How Much It'd Be Worth Now"}, {"id":142356807,"url":"https://finnhub.io/api/news?id=0de55bff1d696d2f4e3db49773c5db70a97bf73c70962931774c79d9383205db","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Agilent Technologies (NYSE:A) executives outlined continued growth momentum, driven by improving end markets, market-share gains, instrument replacement cycles and operational changes under the company’s Ignite transformation program, during a J.P. Morgan conference discussion. Chief Executive Offi","category":"company","datetime":1790161325,"headline":"Agilent Technologies Sees Growth From China, Replacement Cycles and Lab Automation"}, {"id":142361017,"url":"https://finnhub.io/api/news?id=370b63c77df39cee79edef82022a7c1815f2f1568590cf120b0fa4321350be66","image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","source":"SeekingAlpha","related":"A","summary":"Agilent Technologies, Inc. (A) U.S.","category":"company","datetime":1790158171,"headline":"Agilent Technologies, Inc. (A) Presents at U.S. All Stars Conference Transcript"}, {"id":142337961,"url":"https://finnhub.io/api/news?id=2a763a94071e5b5b3e92356501cf788fc2932bb0f3fc59f8286178b69e923cfd","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Let’s dig into the relative performance of Agilent (NYSE:A) and its peers as we unravel the now-completed Q2 research tools & consumables earnings season.","category":"company","datetime":1790085466,"headline":"Research Tools & Consumables Stocks Q2 Highlights: Agilent (NYSE:A)"}, {"id":142338460,"url":"https://finnhub.io/api/news?id=facc7d733c61312e87f12ef4d694ac2ddb37e0733b8ac0abb04429aa45115ef4","image":"https://cdn.benzinga.com/files/images/story/2026/09/22/Moderna--Inc.jpg?width=2048&height=1536","source":"Benzinga","related":"A","summary":"Thermo Fisher, Moderna and Agilent show overbought RSI readings above 70, warning momentum-focused investors of potential near-term weakness.","category":"company","datetime":1790067421,"headline":"Top 3 Health Care Stocks That May Keep You Up At Night This Month"}, {"id":142328473,"url":"https://finnhub.io/api/news?id=e369c6d3a7740fa0482ed3e05ed6e25fa998b4a79f4b73c1dfe9093a80aa3341","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Demand is rising for real-time biomolecular analysis in drug discovery and diagnostics, driven by SPR/BLI advances, automation, high-throughput screening and biomarker research.Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- \"Label-free Array Systems - Global Strategic Business Report\" has been added to ResearchAndMarkets.com's offering.The global market for Label-free Array Systems was valued at US$1.8 Billion in 2024 and is projected to reach US$2.4 Billion by 2030, growing at a CAGR of 5.6% from 2","category":"company","datetime":1790065860,"headline":"Capitalize on Label-Free Array Systems Disruption: Benchmark Agilent, Cytiva, Sartorius, Bio-Rad and PerkinElmer to Secure R&D ROI and Global Market Share"}, {"id":142328474,"url":"https://finnhub.io/api/news?id=85efb7d8043da2785c44589fe07e464369b52343ea3a62c863b956ea862cb220","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"AI-enabled, microfluidic label-free detection is expanding in drug discovery, early diagnostics, food safety and environmental testing, driven by efficient, non-invasive, sustainable workflows.Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- \"Label-Free Detection - Global Strategic Business Report\" has been added to ResearchAndMarkets.com's offering.The global market for Label-Free Detection was valued at US$553 Million in 2024 and is projected to reach US$847 Million by 2030, growing at a CAGR of 7.4","category":"company","datetime":1790065560,"headline":"Capitalize on the Label-Free Detection Market Shift: Track How Danaher, Sartorius, Agilent, Bruker and Revvity Are Disrupting R&D ROI and Reshaping Global Revenue Through 2030"}, {"id":142319334,"url":"https://finnhub.io/api/news?id=63cfec65e1296d673774cfe83ab8d852428dbbe9d27f5f08ca03235d5764f64d","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1402359102/image_1402359102.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"A","summary":"China lithium prices slide as key mine loses licence, while major producers’ profits and Argentina expansion plans reshape 2027 supply outlook. See more here.","category":"company","datetime":1790032673,"headline":"Lithium Miners News For The Month Of September 2026"}, {"id":142311233,"url":"https://finnhub.io/api/news?id=9d33e3b98240b8362767a6d58444adc837b9eaf4573e6e96fc872f94d3a98844","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"SANTA CLARA, Calif., September 21, 2026--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent 4150 TapeStationDx system, Agilent 4200 TapeStationDx system and Agilent TapeStationDx software, extending the company's automated electrophoresis portfolio into regulated clinical laboratory environments. The new CE-IVD-labeled systems and software are designed to support standardized and traceable quality control of DNA and RNA samples used in clinical next-generation sequenci","category":"company","datetime":1789992000,"headline":"Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control"}, {"id":142273886,"url":"https://finnhub.io/api/news?id=06df38de604e000d8f6802cbd0cf46b5d04f40b254df788d5972b6ed8675f93e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"On September 4, Agilent Technologies (NYSE:A) launched a slide scanner in the United States that can hold up to 540 glass slides at once. The Agilent S540MD has FDA clearance and targets labs buried in samples and eyeing AI-assisted workflows. The launch is easy to overlook, but it arrives alongside a strong quarter, and that […]","category":"company","datetime":1789847537,"headline":"Agilent (A) Wants Pathology Labs To Go Digital, 540 Slides At A Time"}, {"id":142205326,"url":"https://finnhub.io/api/news?id=836ad00bc8eaf0ad8256819cef76327267db772e7c6f54e56e9dfd0922ddee0f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"SANTA CLARA, Calif., September 16, 2026--First paragraph, second sentence of release should read: The quarterly dividend will be paid on October 28, 2026, to all shareholders of record as of the close of business on October 6, 2026. (instead of The quarterly dividend will be paid on October 6, 2026, to all shareholders of record as of the close of business on October 28, 2026.).","category":"company","datetime":1789599540,"headline":"CORRECTING and REPLACING Agilent Announces Cash Dividend of 25.5 Cents per Share"}, {"id":142188545,"url":"https://finnhub.io/api/news?id=cd034a92a607fd30359472ceede471c95a8b2c2cc069860151c4a4abc9e53095","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.","category":"company","datetime":1789552069,"headline":"1 Large-Cap Stock to Own for Decades and 2 We Turn Down"}, {"id":142158527,"url":"https://finnhub.io/api/news?id=4a265c8b205d3190ce371ca07c41b1920274ca0eb20b09f3957e92f34d13ea7d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"The global mass spectrometry market is projected to grow from USD 7.07 billion in 2026 to USD 10.78 billion by 2031, at an 8.8% CAGR. Growth is driven by precision medicine, biologics, multi-omics research, regulatory bioanalysis, and food and environmental testing. Instruments and LC-MS will lead the market, supported by high-resolution platforms, AI-enabled analytics, automation, and cloud-connected workflows. Pharmaceutical companies remain the largest end users, while Asia Pacific is expecte","category":"company","datetime":1789462440,"headline":"Global Mass Spectrometry Market to Reach USD 10.78 Billion by 2031, Driven by Biologics, Precision Medicine and LC-MS/MS Adoption"}
data_source finnhub_news_keyword_model
article_count 8
negative_hits 0
positive_hits 0
recomputed_at_score true
sentiment_score_raw 0
source_article_count 36
discarded_article_count 27
sentimentPoints 2

Dimension contribution

Dimension Raw Max Norm % Contrib
基本面 3.6 5/110 72% 3.6
資金流 14.8 20/110 74% 14.8
市場環境 12.2 15/110 81.33% 12.2
催化劑 2 20/110 10% 2
風險管理 6.8 10/110 68% 6.8
技術信號 19.4 30/110 64.67% 19.4
情緒分析 2 10/110 20% 2

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 4/50
ret_5d 0.029
max_score 50
max_total 50
raw_total 4
vcp_bonus 0
vol_ratio 0.9232
ret_points 4
vol_points 0
range_ratio 0.7481
volat_points 0
day_range_pct 0.0221
model_version cursor_18_27_news_v2_160
available_bars 30
breakout_points 0
partial_history false
pullback_points 0
breakout_vol_bonus 0
first_breakout_20d false
return_window_days 5
first_breakout_bonus 0
breakout_quality_points 0

Risk management

level Medium
reason risk management score >= 6.5/10

position

score 1.6

details

atrPct 2.6486
turnoverUsdM 409.8909
liquidityPoints 0.6
volatilityPoints 1
rrPoints 1.4

stopLevels

symbol US.A
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 164.7828

strength_details

ma_score 1.5
atr_score 2
rsi_score 2
macd_score 1.5
volume_score 1
market_adjustment 1
risk_reward_ratio 1
stop_loss_percent 5.3
take_profit_price 183.1942
target_multiplier 1.9
technical_strength 1.58
take_profit_percent 5.3
positionPoints 1.6
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 5.2972
diversificationPoints 2

Calculation audit log

基本面分析總分: 3.6/5分
資金流分析總分: 14.8/20分
市場環境分析總分: 12.2/15分
催化劑分析: 2/20分
風險管理總分: 6.8/10分
技術信號分析總分: 19.4/30分
情緒分析: 2/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx
value 78.57
atr
atr 4.6086
rule ATR / current price; lower volatility scores higher
score 6
atr_pct 2.65
cci
rule Cursor_18.24 CCI bands
level 強勢區
score 10
value 88.48
cmf
rule Cursor_18.24 CMF bands
level 資金流入
score 8
value 0.2869
kdj
d 56.37
j 79.35
k 64.03
rule Cursor_18.24 K/D cross
score 6
signal 強金叉
mfi
rule Cursor_18.24 MFI bands
level 平衡
score 6
value 57.8
obv
rule Cursor_18.24 recent_slope vs previous_slope
score 8
trend 資金入貨
value 16447960
recentSlope 385949.5
previousSlope 333830
rsi
value 52.36
sar
rule Cursor_18.24 Parabolic SAR
score 6
trend 下降
value 174.8027
position SAR接近價
distancePct 0.46
previousTrend 下降
ma50
value 157.571
macd
macd 4.6048
trend 中性偏多
signal 4.9423
histogram -0.3375
vwap
rule Cursor_18.24 VWAP 20D consecutive close
score 10
value 167.2887
position 連續5日>VWAP
consecutiveAbove 21
volume
rule Cursor_18.24 volume ratio
level 無力
ratio 0.93
score 4
avgVolume 2543985
currentVolume 2355695
derived
ma20 168.766
ma50 157.571
prevClose 171.6
avgVolume10 2093270
avgVolume20 2543985
changePercent 1.4
avgVolumeForScore 2543985
ma_cross
ma20 168.766
ma50 157.571
rule Cursor_18.24 MA20/MA50 cross
cross 多頭
score 4
prevMa20 167.7505
prevMa50 156.875
spreadPct 7.1
isVolumeBreakout false
bollinger
lower 158.2773
upper 179.2547
position 上半部
rsi_short
value 83.4
macd_short
macd 0
trend 中性
signal 0
histogram 0
volume_ratio
ratio 0.93

Raw calculation JSON

 
{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.6486206896551723,
        "turnoverUsdM": 409.89093,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.A",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 164.7828,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2,
        "rsi_score": 2,
        "macd_score": 1.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 5.3,
      "take_profit_price": 183.1942,
      "target_multiplier": 1.9,
      "technical_strength": 1.58,
      "take_profit_percent": 5.3
    },
    "positionPoints": 1.6,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 5.2972413793103446,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 64.8,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 60.8,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 4
  },
  "market": {
    "ma20": 168.766,
    "ma50": 157.571,
    "close": 174,
    "prevClose": 171.6,
    "avgVolume20": 2543985,
    "volumeRatio": 0.93,
    "changePercent": 1.4
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 4,
    "details": {
      "ret_5d": 0.02903781486871626,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 4,
      "vcp_bonus": 0,
      "vol_ratio": 0.9232281111544393,
      "ret_points": 4,
      "vol_points": 0,
      "range_ratio": 0.7481049595088158,
      "volat_points": 0,
      "day_range_pct": 0.022068908045977012,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 0,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 64.8,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.6,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 72,
        "contribution": 3.6
      },
      {
        "raw": 14.8,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 74,
        "contribution": 14.8
      },
      {
        "raw": 12.2,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 81.33,
        "contribution": 12.2
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 6.8,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 68,
        "contribution": 6.8
      },
      {
        "raw": 19.4,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 64.67,
        "contribution": 19.4
      },
      {
        "raw": 2,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 20,
        "contribution": 2
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 60.8,
    "details": [
      "基本面分析總分: 3.6/5分",
      "資金流分析總分: 14.8/20分",
      "市場環境分析總分: 12.2/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 6.8/10分",
      "技術信號分析總分: 19.4/30分",
      "情緒分析: 2/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3.6,
      "資金流": 14.8,
      "市場環境": 12.2,
      "情緒分析": 2,
      "技術信號": 19.4,
      "風險管理": 6.8
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "良好",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0.75,
          "debtPoints": 0.5,
          "marginPoints": 0.6,
          "turnoverUsdM": 409.89093,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "良好",
        "items": {
          "cmfPoints": 3.2,
          "mfiPoints": 2.4,
          "obvPoints": 3.2,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.A",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "優秀",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 15.27
            }
          },
          "trend": {
            "score": 2.8,
            "details": {
              "qqq": {
                "ma20": 742.5420041499999,
                "ma50": 726.6542014600002,
                "name": "QQQ",
                "close": 728.84003,
                "points": 1.4
              },
              "spy": {
                "ma20": 770.64649665,
                "ma50": 768.5679965799999,
                "name": "SPY",
                "close": 769.59998,
                "points": 1.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.6486206896551723,
          "atrPoints": 3,
          "cciPoints": 4,
          "vixPoints": 2.4,
          "marketTrendPoints": 2.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 0,
              "sentimentScoreRaw": 0
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 142820200,
                "url": "https://finnhub.io/api/news?id=e5b5228a892afb854995ba185b865f6af7d31e47c95767cdc2d37e77e167926f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Here is how Agilent Technologies (A) and Concentra Group (CON) have performed compared to their sector so far this year.",
                "category": "company",
                "datetime": 1791808802,
                "headline": "Is Agilent Technologies (A) Outperforming Other Medical Stocks This Year?"
              },
              {
                "id": 142731215,
                "url": "https://finnhub.io/api/news?id=b9ad7f7c83f68f77f768b32672fe150f58440903e569bbc9921aca0b44bb676c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Agilent Technologies has delivered a solid share price run over recent years, and the question now is whether the current valuation is properly backed by the cash the business can generate. With fresh investment in new labs and instruments on the table, investors are asking how those projects feed into the stock's intrinsic value based on its cash flows. Over the past 3 years the stock has returned 52.5%, which puts real weight on whether cash generation can support the price that move has...",
                "category": "company",
                "datetime": 1791479981,
                "headline": "Is Agilent Technologies (A) Cheap Enough To Justify Its Cash Flow?"
              },
              {
                "id": 142633835,
                "url": "https://finnhub.io/api/news?id=2eb8408fc2372f0d7df88dbbc9133e3a1155d872cc69ffa7774a7678864fa389",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2276411485/image_2276411485.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "A",
                "summary": "First Trust Water ETF keeps underperforming the broader market, implying that there's more to consider than just demand. I rate the FIW ETF as Sell. Click to read my analysis.",
                "category": "company",
                "datetime": 1791185457,
                "headline": "FIW: Massive Water Infrastructure Needs Aren't Enough To Justify A Buy"
              },
              {
                "id": 142445426,
                "url": "https://finnhub.io/api/news?id=9c786dfccd5c711947457a233c7a6a55226c5e0c02b2d5e54c9a5e36229e194e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Agilent Technologies (A) drew fresh investor attention after announcing a fixed income exchange offer for its 4.900% senior unsecured notes due January 15, 2032, covering a principal amount of US$600 million. Recent action around Agilent Technologies reflects that investors are leaning into the story again, with a 7 day share price return of 10.43% and a 90 day share price return of 30.08% helping lift the stock to US$172.79. That momentum sits on top of a 1 year total shareholder return of...",
                "category": "company",
                "datetime": 1790489579,
                "headline": "Agilent Technologies (A) Tests Valuation On Exchange Offer And Recurring Revenue Story"
              },
              {
                "id": 142424027,
                "url": "https://finnhub.io/api/news?id=21f3938831580f724b9108ab61b3b50cce4c3608a5dfc9c7465bba7828a0d0f6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1790346602,
                "headline": "Agilent (A) Up 9.6% Since Last Earnings Report: Can It Continue?"
              },
              {
                "id": 142359782,
                "url": "https://finnhub.io/api/news?id=2efb73205e56e8222fc2807fee31ad68e98497908bfe9dc63b4c19798931f4ce",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.",
                "category": "company",
                "datetime": 1790166613,
                "headline": "If You Invested $1000 in Agilent Technologies a Decade Ago, This is How Much It'd Be Worth Now"
              },
              {
                "id": 142361017,
                "url": "https://finnhub.io/api/news?id=370b63c77df39cee79edef82022a7c1815f2f1568590cf120b0fa4321350be66",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "A",
                "summary": "Agilent Technologies, Inc. (A) U.S.",
                "category": "company",
                "datetime": 1790158171,
                "headline": "Agilent Technologies, Inc. (A) Presents at U.S. All Stars Conference Transcript"
              },
              {
                "id": 142337961,
                "url": "https://finnhub.io/api/news?id=2a763a94071e5b5b3e92356501cf788fc2932bb0f3fc59f8286178b69e923cfd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Let’s dig into the relative performance of Agilent (NYSE:A) and its peers as we unravel the now-completed Q2 research tools & consumables earnings season.",
                "category": "company",
                "datetime": 1790085466,
                "headline": "Research Tools & Consumables Stocks Q2 Highlights: Agilent (NYSE:A)"
              }
            ],
            "raw_source": [
              {
                "id": 142880640,
                "url": "https://finnhub.io/api/news?id=f59fb84a1dddc2400f63f414be29dad3e7429ba4db920560f5af7615a7d1d9b4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "The transaction, which is expected to close in Agilent’s fiscal year 2027, follows its $950m acquisition of Biocare Medical in March 2026.",
                "category": "company",
                "datetime": 1791976316,
                "headline": "Agilent acquires Proscia in deal worth up to $270m"
              },
              {
                "id": 142884529,
                "url": "https://finnhub.io/api/news?id=c5802bcda140f286c39d247fed77151eb14a83c236706ed9d72001d98e550db9",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/14/Business-Mergers-And-Acquisitions-Concep.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "A",
                "summary": "Agilent (A) to acquire Proscia for up to $270M to expand AI-powered digital pathology & diagnostic capabilities. Stock edges higher.",
                "category": "company",
                "datetime": 1791969631,
                "headline": "Why Agilent Is Spending up to $270 Million on an AI Pathology Specialist"
              },
              {
                "id": 142872383,
                "url": "https://finnhub.io/api/news?id=f787c7b9b42d55a03cd4a0b6dcda8b2030c5da929b0fc2afc9f13417433f89b2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Players: Metabolon, Bruker, Agilent, Thermo Fisher and Waters. Profiles cover products, services, market share, segments, trends, opportunities and regional presence.Dublin, Oct. 14, 2026 (GLOBE NEWSWIRE) -- \"Metabolomics Market Report 2026\" has been added to ResearchAndMarkets.com's offering. The global metabolomics market is experiencing rapid expansion, driven by advances in biomarker discovery, personalized medicine, cancer research and analytical technologies. The market grew from $4.17 bil",
                "category": "company",
                "datetime": 1791965160,
                "headline": "Global Metabolomics Market Report 2026: Size, Trends, and Forecast to 2030 | Capitalize on 17.3% CAGR as Thermo Fisher, Bruker, Agilent, and Metabolon Accelerate AI Diagnostics"
              },
              {
                "id": 142885464,
                "url": "https://finnhub.io/api/news?id=ca55eb1d7732b96a5721dd224220baa4cbf255435598a2e7e851fcfae6a23d8d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "The digital pathology firm “fits in very well” with Agilent and moves the company into a sector targeted by Roche, analysts said.",
                "category": "company",
                "datetime": 1791959378,
                "headline": "Agilent to buy Proscia for $240M"
              },
              {
                "id": 142849053,
                "url": "https://finnhub.io/api/news?id=6fc26925705f3d72cf48b269551fa1c08ea36bb23b3f1ba47d48926b51183b6e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "SANTA CLARA, Calif. & PHILADELPHIA, October 13, 2026--Agilent Technologies Inc. (NYSE: A) today announced it has entered into a definitive agreement to acquire Proscia®, a provider of digital pathology software for clinical and life-sciences customers, in an all-cash transaction valued at $240 million in cash at closing and up to an additional $30 million based on achieving future performance milestones.",
                "category": "company",
                "datetime": 1791892800,
                "headline": "Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence"
              },
              {
                "id": 142884530,
                "url": "https://finnhub.io/api/news?id=c1b0d7a8d698fe1997b21a865b7d9783823b5719b16985faf0da984950fc4655",
                "image": "",
                "source": "Benzinga",
                "related": "A",
                "summary": "TD Cowen  analyst Dan Brennan   maintains Agilent Technologies (NYSE:A) with a Buy and raises the price target from $180 to $196.",
                "category": "company",
                "datetime": 1791891562,
                "headline": "TD Cowen Maintains Buy on Agilent Technologies, Raises Price Target to $196"
              },
              {
                "id": 142884531,
                "url": "https://finnhub.io/api/news?id=9b35f2007459e45e29c82c9aa6d0e52a64c4e923f02492cd7953b9ea18d2b71a",
                "image": "",
                "source": "Benzinga",
                "related": "A",
                "summary": "Morgan Stanley  analyst Kallum Titchmarsh   maintains Agilent Technologies (NYSE:A) with a Overweight and raises the price target from $175 to $190.",
                "category": "company",
                "datetime": 1791891494,
                "headline": "Morgan Stanley Maintains Overweight on Agilent Technologies, Raises Price Target to $190"
              },
              {
                "id": 142839262,
                "url": "https://finnhub.io/api/news?id=d2236c8c28c291f8d06435628151897272438e2c76e2f409c8bed47f16e3d589",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- \"Chromosomal Microarray Reflex Testing Global Market Report 2026\" has been added to ResearchAndMarkets.com's offering. The global chromosomal microarray reflex testing market is experiencing strong growth as healthcare providers increase their use of advanced genomic diagnostics for prenatal, postnatal, oncology, and rare disease applications. The market is projected to grow from $1.39 billion in 2025 to $1.51 billion in 2026, representing a compound ann",
                "category": "company",
                "datetime": 1791878580,
                "headline": "Global Chromosomal Microarray Reflex Testing Market Report 2026-2030 | Capitalize on 9.1% CAGR as Thermo Fisher, LabCorp, Illumina, Agilent, and Natera Scale Precision Genomics"
              },
              {
                "id": 142820200,
                "url": "https://finnhub.io/api/news?id=e5b5228a892afb854995ba185b865f6af7d31e47c95767cdc2d37e77e167926f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Here is how Agilent Technologies (A) and Concentra Group (CON) have performed compared to their sector so far this year.",
                "category": "company",
                "datetime": 1791808802,
                "headline": "Is Agilent Technologies (A) Outperforming Other Medical Stocks This Year?"
              },
              {
                "id": 142731215,
                "url": "https://finnhub.io/api/news?id=b9ad7f7c83f68f77f768b32672fe150f58440903e569bbc9921aca0b44bb676c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Agilent Technologies has delivered a solid share price run over recent years, and the question now is whether the current valuation is properly backed by the cash the business can generate. With fresh investment in new labs and instruments on the table, investors are asking how those projects feed into the stock's intrinsic value based on its cash flows. Over the past 3 years the stock has returned 52.5%, which puts real weight on whether cash generation can support the price that move has...",
                "category": "company",
                "datetime": 1791479981,
                "headline": "Is Agilent Technologies (A) Cheap Enough To Justify Its Cash Flow?"
              },
              {
                "id": 142695688,
                "url": "https://finnhub.io/api/news?id=54b2461c864239e33dfabc7a5f3aa6a8062696dfa72aec15a19b4970dde3fecc",
                "image": "",
                "source": "Benzinga",
                "related": "A",
                "summary": "Barclays  analyst Luke Sergott   maintains Agilent Technologies (NYSE:A) with a Overweight and raises the price target from $175 to $195.",
                "category": "company",
                "datetime": 1791365165,
                "headline": "Barclays Maintains Overweight on Agilent Technologies, Raises Price Target to $195"
              },
              {
                "id": 142647609,
                "url": "https://finnhub.io/api/news?id=c842fcc48355b415ae781153021086982bc5ef2315cf2c17223cf25039995173",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2163482326/image_2163482326.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "A",
                "summary": "Technology was the only sector to gain in September as mega-cap strength masked broad market weakness. Read more here.",
                "category": "company",
                "datetime": 1791250200,
                "headline": "Moat Stocks Retreat As Market Breadth Narrows"
              },
              {
                "id": 142633835,
                "url": "https://finnhub.io/api/news?id=2eb8408fc2372f0d7df88dbbc9133e3a1155d872cc69ffa7774a7678864fa389",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2276411485/image_2276411485.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "A",
                "summary": "First Trust Water ETF keeps underperforming the broader market, implying that there's more to consider than just demand. I rate the FIW ETF as Sell. Click to read my analysis.",
                "category": "company",
                "datetime": 1791185457,
                "headline": "FIW: Massive Water Infrastructure Needs Aren't Enough To Justify A Buy"
              },
              {
                "id": 142593872,
                "url": "https://finnhub.io/api/news?id=499bf9bb38b2e7b37ffd4baa210386aa2765fea7f5aabdb08f96d7dabdf7322d",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "A",
                "summary": "Track weekly dividend updates for Dividend Champions, Contenders & Challengers—see dividend changes, upcoming ex-dividend and pay dates. Read it here.",
                "category": "company",
                "datetime": 1790965134,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week October 4"
              },
              {
                "id": 142559868,
                "url": "https://finnhub.io/api/news?id=8b175ceb5b7bff39983b76422ee597a0905fad70b8d2ff3eeb3a31a160e63ea4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1790865004,
                "headline": "Why Is Medtronic (MDT) Down 6.4% Since Last Earnings Report?"
              },
              {
                "id": 142588193,
                "url": "https://finnhub.io/api/news?id=309bd205640725159056e0eb9ab31f49a57990c5d5ed2d0ca8a7b06b3613fb67",
                "image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_3.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "A",
                "summary": "Agilent Technologies (NYSE:A) has outperformed the market over the past 15 years by 1.05% on an annualized basis producing an average annual return of 14.43%. Currently, Agilent Technologies has a market capitalization",
                "category": "company",
                "datetime": 1790858747,
                "headline": "$1000 Invested In Agilent Technologies 15 Years Ago Would Be Worth This Much Today"
              },
              {
                "id": 142557959,
                "url": "https://finnhub.io/api/news?id=8a17cf1a74d2ef0a8e32e203d206f2395bdb550fe0f0e12abcf88e004c2922dc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "SANTA CLARA, Calif., October 01, 2026--Agilent Technologies Inc. (NYSE: A) today announced the launch of the NovoStation Sample Preparation System, a new automated platform designed to help laboratories simplify and streamline flow cytometry sample preparation. When paired with a NovoCyte flow cytometer and NovoExpress software, NovoStation offers an integration-ready solution that enables a hands-free sample-to-answer workflow, helping scientists spend less time preparing samples and more time",
                "category": "company",
                "datetime": 1790856000,
                "headline": "Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows"
              },
              {
                "id": 142496160,
                "url": "https://finnhub.io/api/news?id=ef18193aa55d6b8032d176e715ec487656be230854007991936e0d42bbb488e7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "SANTA CLARA, Calif., September 29, 2026--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent BioTek Gen5 AI cell identification module, a new image analysis software add-on that incorporates AI-based cell identification and segmentation into BioTek Gen5 imaging analysis.",
                "category": "company",
                "datetime": 1790683200,
                "headline": "Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers"
              },
              {
                "id": 142463307,
                "url": "https://finnhub.io/api/news?id=2a2c59b622ef2cae5b0b5c0f8089761a5aa4c5cfac4ea08d75d8dc51e8bbe26b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 46.9% gain over the past six months, beating the S&P 500 by 25.5 percentage points.",
                "category": "company",
                "datetime": 1790587116,
                "headline": "3 Healthcare Stocks That Fall Short"
              },
              {
                "id": 142445426,
                "url": "https://finnhub.io/api/news?id=9c786dfccd5c711947457a233c7a6a55226c5e0c02b2d5e54c9a5e36229e194e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Agilent Technologies (A) drew fresh investor attention after announcing a fixed income exchange offer for its 4.900% senior unsecured notes due January 15, 2032, covering a principal amount of US$600 million. Recent action around Agilent Technologies reflects that investors are leaning into the story again, with a 7 day share price return of 10.43% and a 90 day share price return of 30.08% helping lift the stock to US$172.79. That momentum sits on top of a 1 year total shareholder return of...",
                "category": "company",
                "datetime": 1790489579,
                "headline": "Agilent Technologies (A) Tests Valuation On Exchange Offer And Recurring Revenue Story"
              },
              {
                "id": 142424027,
                "url": "https://finnhub.io/api/news?id=21f3938831580f724b9108ab61b3b50cce4c3608a5dfc9c7465bba7828a0d0f6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1790346602,
                "headline": "Agilent (A) Up 9.6% Since Last Earnings Report: Can It Continue?"
              },
              {
                "id": 142385317,
                "url": "https://finnhub.io/api/news?id=f6f2a26b9f5647288b5da04eda91284fe1679478b8b585e97013ed1ba637efe8",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "A",
                "summary": "Stay updated with the movements of the S&P500 index one hour before the close of the markets on Thursday. Discover which stocks are leading as top gainers and losers in today's session.",
                "category": "company",
                "datetime": 1790276701,
                "headline": "Discover which S&P500 stocks are making waves on Thursday."
              },
              {
                "id": 142384123,
                "url": "https://finnhub.io/api/news?id=dc1a57203f768e8c465d0c09732c290a21cef549361c1549da309d17b77fc56a",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "A",
                "summary": "Curious about the top performers within the S&P500 index in the middle of the day on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.",
                "category": "company",
                "datetime": 1790267701,
                "headline": "Explore the top gainers and losers within the S&P500 index in today's session."
              },
              {
                "id": 142359782,
                "url": "https://finnhub.io/api/news?id=2efb73205e56e8222fc2807fee31ad68e98497908bfe9dc63b4c19798931f4ce",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.",
                "category": "company",
                "datetime": 1790166613,
                "headline": "If You Invested $1000 in Agilent Technologies a Decade Ago, This is How Much It'd Be Worth Now"
              },
              {
                "id": 142356807,
                "url": "https://finnhub.io/api/news?id=0de55bff1d696d2f4e3db49773c5db70a97bf73c70962931774c79d9383205db",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Agilent Technologies (NYSE:A) executives outlined continued growth momentum, driven by improving end markets, market-share gains, instrument replacement cycles and operational changes under the company’s Ignite transformation program, during a J.P. Morgan conference discussion. Chief Executive Offi",
                "category": "company",
                "datetime": 1790161325,
                "headline": "Agilent Technologies Sees Growth From China, Replacement Cycles and Lab Automation"
              },
              {
                "id": 142361017,
                "url": "https://finnhub.io/api/news?id=370b63c77df39cee79edef82022a7c1815f2f1568590cf120b0fa4321350be66",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "A",
                "summary": "Agilent Technologies, Inc. (A) U.S.",
                "category": "company",
                "datetime": 1790158171,
                "headline": "Agilent Technologies, Inc. (A) Presents at U.S. All Stars Conference Transcript"
              },
              {
                "id": 142337961,
                "url": "https://finnhub.io/api/news?id=2a763a94071e5b5b3e92356501cf788fc2932bb0f3fc59f8286178b69e923cfd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Let’s dig into the relative performance of Agilent (NYSE:A) and its peers as we unravel the now-completed Q2 research tools & consumables earnings season.",
                "category": "company",
                "datetime": 1790085466,
                "headline": "Research Tools & Consumables Stocks Q2 Highlights: Agilent (NYSE:A)"
              },
              {
                "id": 142338460,
                "url": "https://finnhub.io/api/news?id=facc7d733c61312e87f12ef4d694ac2ddb37e0733b8ac0abb04429aa45115ef4",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/22/Moderna--Inc.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "A",
                "summary": "Thermo Fisher, Moderna and Agilent show overbought RSI readings above 70, warning momentum-focused investors of potential near-term weakness.",
                "category": "company",
                "datetime": 1790067421,
                "headline": "Top 3 Health Care Stocks That May Keep You Up At Night This Month"
              },
              {
                "id": 142328473,
                "url": "https://finnhub.io/api/news?id=e369c6d3a7740fa0482ed3e05ed6e25fa998b4a79f4b73c1dfe9093a80aa3341",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Demand is rising for real-time biomolecular analysis in drug discovery and diagnostics, driven by SPR/BLI advances, automation, high-throughput screening and biomarker research.Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- \"Label-free Array Systems - Global Strategic Business Report\" has been added to ResearchAndMarkets.com's offering.The global market for Label-free Array Systems was valued at US$1.8 Billion in 2024 and is projected to reach US$2.4 Billion by 2030, growing at a CAGR of 5.6% from 2",
                "category": "company",
                "datetime": 1790065860,
                "headline": "Capitalize on Label-Free Array Systems Disruption: Benchmark Agilent, Cytiva, Sartorius, Bio-Rad and PerkinElmer to Secure R&D ROI and Global Market Share"
              },
              {
                "id": 142328474,
                "url": "https://finnhub.io/api/news?id=85efb7d8043da2785c44589fe07e464369b52343ea3a62c863b956ea862cb220",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "AI-enabled, microfluidic label-free detection is expanding in drug discovery, early diagnostics, food safety and environmental testing, driven by efficient, non-invasive, sustainable workflows.Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- \"Label-Free Detection - Global Strategic Business Report\" has been added to ResearchAndMarkets.com's offering.The global market for Label-Free Detection was valued at US$553 Million in 2024 and is projected to reach US$847 Million by 2030, growing at a CAGR of 7.4",
                "category": "company",
                "datetime": 1790065560,
                "headline": "Capitalize on the Label-Free Detection Market Shift: Track How Danaher, Sartorius, Agilent, Bruker and Revvity Are Disrupting R&D ROI and Reshaping Global Revenue Through 2030"
              },
              {
                "id": 142319334,
                "url": "https://finnhub.io/api/news?id=63cfec65e1296d673774cfe83ab8d852428dbbe9d27f5f08ca03235d5764f64d",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1402359102/image_1402359102.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "A",
                "summary": "China lithium prices slide as key mine loses licence, while major producers’ profits and Argentina expansion plans reshape 2027 supply outlook. See more here.",
                "category": "company",
                "datetime": 1790032673,
                "headline": "Lithium Miners News For The Month Of September 2026"
              },
              {
                "id": 142311233,
                "url": "https://finnhub.io/api/news?id=9d33e3b98240b8362767a6d58444adc837b9eaf4573e6e96fc872f94d3a98844",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "SANTA CLARA, Calif., September 21, 2026--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent 4150 TapeStationDx system, Agilent 4200 TapeStationDx system and Agilent TapeStationDx software, extending the company's automated electrophoresis portfolio into regulated clinical laboratory environments. The new CE-IVD-labeled systems and software are designed to support standardized and traceable quality control of DNA and RNA samples used in clinical next-generation sequenci",
                "category": "company",
                "datetime": 1789992000,
                "headline": "Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control"
              },
              {
                "id": 142273886,
                "url": "https://finnhub.io/api/news?id=06df38de604e000d8f6802cbd0cf46b5d04f40b254df788d5972b6ed8675f93e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "On September 4, Agilent Technologies (NYSE:A) launched a slide scanner in the United States that can hold up to 540 glass slides at once. The Agilent S540MD has FDA clearance and targets labs buried in samples and eyeing AI-assisted workflows. The launch is easy to overlook, but it arrives alongside a strong quarter, and that […]",
                "category": "company",
                "datetime": 1789847537,
                "headline": "Agilent (A) Wants Pathology Labs To Go Digital, 540 Slides At A Time"
              },
              {
                "id": 142205326,
                "url": "https://finnhub.io/api/news?id=836ad00bc8eaf0ad8256819cef76327267db772e7c6f54e56e9dfd0922ddee0f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "SANTA CLARA, Calif., September 16, 2026--First paragraph, second sentence of release should read: The quarterly dividend will be paid on October 28, 2026, to all shareholders of record as of the close of business on October 6, 2026. (instead of The quarterly dividend will be paid on October 6, 2026, to all shareholders of record as of the close of business on October 28, 2026.).",
                "category": "company",
                "datetime": 1789599540,
                "headline": "CORRECTING and REPLACING Agilent Announces Cash Dividend of 25.5 Cents per Share"
              },
              {
                "id": 142188545,
                "url": "https://finnhub.io/api/news?id=cd034a92a607fd30359472ceede471c95a8b2c2cc069860151c4a4abc9e53095",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.",
                "category": "company",
                "datetime": 1789552069,
                "headline": "1 Large-Cap Stock to Own for Decades and 2 We Turn Down"
              },
              {
                "id": 142158527,
                "url": "https://finnhub.io/api/news?id=4a265c8b205d3190ce371ca07c41b1920274ca0eb20b09f3957e92f34d13ea7d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "The global mass spectrometry market is projected to grow from USD 7.07 billion in 2026 to USD 10.78 billion by 2031, at an 8.8% CAGR. Growth is driven by precision medicine, biologics, multi-omics research, regulatory bioanalysis, and food and environmental testing. Instruments and LC-MS will lead the market, supported by high-resolution platforms, AI-enabled analytics, automation, and cloud-connected workflows. Pharmaceutical companies remain the largest end users, while Asia Pacific is expecte",
                "category": "company",
                "datetime": 1789462440,
                "headline": "Global Mass Spectrometry Market to Reach USD 10.78 Billion by 2031, Driven by Biologics, Precision Medicine and LC-MS/MS Adoption"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 0,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0,
            "source_article_count": 36,
            "discarded_article_count": 27
          },
          "sentimentPoints": 2
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 19.4,
        "grade": "一般",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 1.7999999999999998,
          "vcpPoints": 1.6,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1.6,
            "vcp_reason": "波幅收縮(20.6%→7.5%)；站上MA50；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 5,
              "vol_ref": 2368056.6666666665,
              "down_days": 4,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 2116740,
              "avg_vol_20": 2551585,
              "avg_vol_30": 2368056.6666666665,
              "range_pct_10": 0.07505741379310345,
              "range_pct_20": 0.1537356494252873,
              "range_pct_30": 0.20574714367816094,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": false,
              "up_expand_days": 0,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.893872190558503,
              "dist_to_20d_high": 0.01722678875074633,
              "down_shrink_days": 1,
              "breakout_level_20d": 177.050003,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.3648041593739531
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.8,
          "rsiKdjPoints": 3.2,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0.8,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 0.8
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.6486206896551723,
              "turnoverUsdM": 409.89093,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.A",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 164.7828,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2,
              "rsi_score": 2,
              "macd_score": 1.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 5.3,
            "take_profit_price": 183.1942,
            "target_multiplier": 1.9,
            "technical_strength": 1.58,
            "take_profit_percent": 5.3
          },
          "positionPoints": 1.6,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 5.2972413793103446,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 78.57,
    "atr": {
      "atr": 4.6086,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.65
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "強勢區",
      "score": 10,
      "value": 88.48
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "資金流入",
      "score": 8,
      "value": 0.2869
    },
    "kdj": {
      "d": 56.37,
      "j": 79.35,
      "k": 64.03,
      "rule": "Cursor_18.24 K/D cross",
      "score": 6,
      "signal": "強金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "平衡",
      "score": 6,
      "value": 57.8
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 8,
      "trend": "資金入貨",
      "value": 16447960,
      "recentSlope": 385949.5,
      "previousSlope": 333830
    },
    "rsi": 52.36,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 6,
      "trend": "下降",
      "value": 174.8027,
      "position": "SAR接近價",
      "distancePct": 0.46,
      "previousTrend": "下降"
    },
    "ma50": 157.571,
    "macd": {
      "macd": 4.604788300686266,
      "trend": "中性偏多",
      "signal": 4.942325202487995,
      "histogram": -0.33753690180172846
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 167.2887,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 21
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "無力",
      "ratio": 0.93,
      "score": 4,
      "avgVolume": 2543985,
      "currentVolume": 2355695
    },
    "derived": {
      "ma20": 168.766,
      "ma50": 157.571,
      "prevClose": 171.6,
      "avgVolume10": 2093270,
      "avgVolume20": 2543985,
      "changePercent": 1.4,
      "avgVolumeForScore": 2543985
    },
    "ma_cross": {
      "ma20": 168.766,
      "ma50": 157.571,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 167.7505,
      "prevMa50": 156.875,
      "spreadPct": 7.1,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 158.2773,
      "upper": 179.2547,
      "position": "上半部"
    },
    "rsi_short": 83.4,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.93
    }
  }
}

Raw metrics JSON

 
{
  "close": 174,
  "volume": 2355695,
  "changePercent": 1.4
}

Scores are derived from cached daily market data using the Solorank 110-point standard. Solorank provides research support only and does not provide financial advice or buy/sell recommendations.